Basic science of osteoarthritis

被引：72
作者：
Cucchiarini M. [1 ]
de Girolamo L. [2 ]
Filardo G. [3 ]
Oliveira J.M. [4 ,5 ]
Orth P. [1 ,6 ]
Pape D. [7 ,8 ]
Reboul P. [9 ]
机构：
[1] Center of Experimental Orthopaedics, Saarland University Medical Center and Saarland University, Kirrbergerstr. Bldg 37, Homburg
[2] Orthopaedic Biotechnology Laboratory, Galeazzi Orthopaedic Institute, Milan
[3] Orthopaedic and Traumatologic I Clinic, Biomechanics Laboratory, Rizzoli Orthopaedic Institute, University of Bologna, Bologna
[4] 3B’s Research Group - Biomaterials, Biodegradables and Biomimetics, Univ. Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, Avepark - Parque de Ciência e Tecnologia, Zona Industrial da Gandra, Barc
[5] ICVS/3B’s - PT Government Associated Laboratory, Barco, Guimarães
[6] Department of Orthopaedic Surgery, Saarland University Medical Center and Saarland University, Homburg, Saar
[7] Department of Orthopaedic Surgery, Centre Hospitalier de Luxembourg, Luxembourg ville
[8] Sports Medicine Research Laboratory, Public Research Centre for Health, Luxembourg, Centre Médical de la Fondation Norbert Metz, Luxembourg ville
[9] UMR 7365 CNRS-Université de Lorraine, IMoPA, Biopôle de l’Université de Lorraine, Campus Biologie-Santé, Vandoeuvre-lès-Nancy
来源：
Journal of Experimental Orthopaedics | / 3卷 / 1期
关键词：
Animal models; Articular cartilage; Bone; Interface; Osteoarthritis; Pathomechanisms; Stem cells; Tissue engineering;
D O I：
10.1186/s40634-016-0060-6
中图分类号：
学科分类号：
摘要：
Osteoarthritis (OA) is a prevalent, disabling disorder of the joints that affects a large population worldwide and for which there is no definitive cure. This review provides critical insights into the basic knowledge on OA that may lead to innovative end efficient new therapeutic regimens. While degradation of the articular cartilage is the hallmark of OA, with altered interactions between chondrocytes and compounds of the extracellular matrix, the subchondral bone has been also described as a key component of the disease, involving specific pathomechanisms controlling its initiation and progression. The identification of such events (and thus of possible targets for therapy) has been made possible by the availability of a number of animal models that aim at reproducing the human pathology, in particular large models of high tibial osteotomy (HTO). From a therapeutic point of view, mesenchymal stem cells (MSCs) represent a promising option for the treatment of OA and may be used concomitantly with functional substitutes integrating scaffolds and drugs/growth factors in tissue engineering setups. Altogether, these advances in the fundamental and experimental knowledge on OA may allow for the generation of improved, adapted therapeutic regimens to treat human OA. © 2016, The Author(s).
引用
收藏
相关论文
共 131 条
[21]  
Chan T.F., Couchourel D., Abed E., Delalandre A., Duval N., Lajeunesse D., Elevated Dickkopf-2 levels contribute to the abnormal phenotype of human osteoarthritic osteoblasts, J Bone Miner Res, 26, 7, pp. 1399-1410, (2011)
[22]  
Chen P., Xia C., Mei S., Wang J., Shan Z., Lin X., Fan S., Intra-articular delivery of sinomenium encapsulated by chitosan microspheres and photo-crosslinked GelMA hydrogel ameliorates osteoarthritis by effectively regulating autophagy, Biomaterials, 81, pp. 1-13, (2016)
[23]  
Christiansen B.A., Guilak F., Lockwood K.A., Olson S.A., Pitsillides A.A., Sandell L.J., Silva M.J., van der Meulen M.C., Haudenschild D.R., Non-invasive mouse models of post-traumatic osteoarthritis, Osteoarthritis Cartilage, 23, 10, pp. 1627-1638, (2015)
[24]  
Couchourel D., Aubry I., Delalandre A., Lavigne M., Martel-Pelletier J., Pelletier J.P., Lajeunesse D., Altered mineralization of human osteoarthritic osteoblasts is attributable to abnormal type I collagen production, Arthritis Rheum, 60, 5, pp. 1438-1450, (2009)
[25]  
Day J.S., Ding M., van der Linden J.C., Hvid I., Sumner D.R., Weinans H., A decreased subchondral trabecular bone tissue elastic modulus is associated with pre-arthritic cartilage damage, J Orthop Res, 19, 5, pp. 914-918, (2001)
[26]  
de Girolamo L., Kon E., Filardo G., Marmotti A.G., Soler F., Peretti G.M., Vannini F., Madry H., Chubinskaya S., Regenerative approaches for the treatment of early OA, Knee Surg Sports Traumatol Arthrosc, 24, 6, pp. 1826-1835, (2016)
[27]  
Driban J.B., Lo G.H., Pric L., Pang J., Miller E., Ward R.J., Hunter D.J., Eaton C.B., Lynch J.A., McAlindon T.E., OAI Investigators Group, Bone marrow lesion volume reduction is not associated with improvement of other periarticular bone measures: data from the Osteoarthritis Initiative, Arthritis Res Ther, 15, 5, pp. R153-R160, (2013)
[28]  
Dumond H., Presle N., Terlain B., Mainard D., Loeuille D., Netter P., Pottie P., Evidence for a key role of leptin in osteoarthritis, Arthritis Rheum, 48, 11, pp. 3118-3129, (2003)
[29]  
Duncan H., Jundt J., Riddle J.M., Pitchford W., Christopherson T., The tibial subchondral plate. A scanning electron microscopic study, J Bone Joint Surg Am, 69, 8, pp. 1212-1220, (1987)
[30]  
Dyke J.P., Aaron R.K., Noninvasive methods of measuring bone blood perfusion, Ann N Y Acad Sci, 1192, pp. 95-102, (2010)
12345678910